Publication | Open Access
Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma
52
Citations
3
References
2019
Year
Anti-PD1 therapy has great potential. Early recognition of the onset of unusual collateral effects is important to improve decision making regarding the treatment of patients with tumors.
| Year | Citations | |
|---|---|---|
Page 1
Page 1